Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Sinco Pharmaceuticals Holdings Ltd. ?
1
Negative results in Dec 24
- OPERATING CASH FLOW(Y) Lowest at HKD 96.94 MM
- CASH AND EQV(HY) Lowest at HKD 437.79 MM
- DEBT-EQUITY RATIO (HY) Highest at -7.05 %
2
Underperformed the market in the last 1 year
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Retailing)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Sinco Pharmaceuticals Holdings Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Sinco Pharmaceuticals Holdings Ltd.
-1.08%
-0.41
65.28%
Hang Seng Hong Kong
27.36%
1.03
25.88%
Quality key factors
Factor
Value
Sales Growth (5y)
13.69%
EBIT Growth (5y)
6.28%
EBIT to Interest (avg)
9.99
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.08
Sales to Capital Employed (avg)
3.41
Tax Ratio
57.49%
Dividend Payout Ratio
8.93%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
55.97%
ROE (avg)
26.01%
Valuation Key Factors 
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
0.69
EV to EBIT
3.49
EV to EBITDA
2.88
EV to Capital Employed
0.66
EV to Sales
0.14
PEG Ratio
10.07
Dividend Yield
4.18%
ROCE (Latest)
18.98%
ROE (Latest)
6.84%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bearish
Technical Movement
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Sinco Pharmaceuticals Holdings Ltd.
Raw Material Cost
Fallen by 1.9% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at HKD 15.51 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (HKD MM)
Depreciation
At HKD 15.51 MM has Grown at 42.82%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (HKD MM)
Here's what is not working for Sinco Pharmaceuticals Holdings Ltd.
Operating Cash Flow
Lowest at HKD 96.94 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (HKD MM)
Interest
Highest at HKD 10.09 MM
in the last five periods and Increased by 26.93% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (HKD MM)
Cash and Eqv
Lowest at HKD 437.79 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at -7.05 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Inventory Turnover Ratio
Lowest at 11.07%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debtors Turnover Ratio
Lowest at 4.92%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio






